The Only Post Market Surveillance Decision You Need to Make
Post Market Surveillance under MDR has become a pain. Believe us, we understand. With multiple documents to juggle, different submission intervals, and (*cough*) ambiguity in the regs, it’s hard to stay organized.
Our team has built the experience, tools and processes to handle it all, year after year. All you have to do let us use them.
EU MDR Submission Expertise
We’ve been in the audit trenches, and aside from a scar or two have lived to submit another day. If we’re handling your submissions, you can rest assured that we’re operating on a breadth of collective experience.
Industry Leading Tools
Your data is too precious and complex to be managed through Excel sheets renamed ‘old’ as a means for version control. Without a system, it’s impossible to maintain a single device document, let alone hundreds of device documents.
That’s why we’ve invested years, and our children’s college funds (just kidding) in building State of the Art tools to keep your Adverse Events, Scientific Literature, and Documents managed.
Our Clients Say
I’ve never seen such a streamlined process for literature search and review. CiteMed produced elegant reports that were easy to read despite their length and incredible detail
Free Articles and Post Market Surveillance Whitepapers
Your Medical Device Got CE Marked – Now What?
Obtaining the CE mark is one of the most significant milestones in the life of most medical devices. Unfortunately, it typically takes years and can exhaust even the most determined regulatory personnel. Nevertheless, getting [...]
Market Surveillance of Medical Devices Under the EU MDR
The term market surveillance covers the activities carried out by national regulatory authorities to ensure the safety and efficiency of products placed on the market. In these activities, the national regulatory authorities put measures [...]
The Post-Market Surveillance Document: Which Ones Do you Need?
It's not enough to make a device and put it on the market—you must know how people use your product. Therefore, the post-market surveillance must cover all devices that have been placed on the market, [...]
Updates To The EU Blue Guide: Impacts on Market Surveillance of Medical Devices
In July 2021, Regulation (EU) 2019/1020 on market surveillance and product compliance, issued by the European Parliament and Council, came into force. The regulation forms the core of European market surveillance law and will [...]
Post-Market Surveillance Process and What It Will Cost You
Post-market surveillance and vigilance costs are overgrowing. For example, the number of reported adverse reactions has increased annually by approximately 10-15% over the past five years. In addition, costs for post-market surveillance have been growing, [...]
Post-Market Surveillance, Market Surveillance, and Vigilance – What is the Difference?
Most regulatory staff can define post-market surveillance relatively succinctly. Perhaps also vigilance. But when it comes to market surveillance, what exactly makes it different from post-market surveillance? And why is vigilance a separate entity [...]
Worry-Free EU MDR Compliance
1. Searching and Data Ingress
CiteMed (Through Automation and Careful Human Auditing) Collects Adverse Event Data from all of your chosen global sources
2. Expert Review of All Search Results
Our team of medical writers reviews the results and classifies any relevant Events for you to be included in the next Vigilance Report. (this is optional).
3. All Results Made Visible on Your Dashboard
Search results as well as our team’s reviews/classifications are immediately available for you to access on your CiteMed Dashboard.
4. Vigilance Report Document Is Delivered
On your chosen time interval, CIteMed delivers an Adverse Event Report to you via email and accessible directly on your CiteMed Dashboard.